137 related articles for article (PubMed ID: 10036612)
1. The effects of dopaminergic D2 stimulation and blockade on smoking behavior.
Caskey NH; Jarvik ME; Wirshing WC
Exp Clin Psychopharmacol; 1999 Feb; 7(1):72-8. PubMed ID: 10036612
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D2 receptor effects on GABA(A) receptor expression may modify melanotrope peptide release.
Sands SA; de Blas AL; Chronwall BM
Peptides; 1998; 19(2):397-401. PubMed ID: 9493875
[TBL] [Abstract][Full Text] [Related]
3. Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man.
Abduljawad KA; Langley RW; Bradshaw CM; Szabadi E
J Psychopharmacol; 1998; 12(3):239-45. PubMed ID: 10958249
[TBL] [Abstract][Full Text] [Related]
4. Modulating tobacco smoking rates by dopaminergic stimulation and blockade.
Caskey NH; Jarvik ME; Wirshing WC; Madsen DC; Iwamoto-Schaap PN; Eisenberger NI; Huerta L; Terrace SM; Olmstead RE
Nicotine Tob Res; 2002 Aug; 4(3):259-66. PubMed ID: 12215234
[TBL] [Abstract][Full Text] [Related]
5. Effects of dopaminergic modulation on electrophysiological brain response to affective stimuli.
Franken IH; Nijs I; Pepplinkhuizen L
Psychopharmacology (Berl); 2008 Jan; 195(4):537-46. PubMed ID: 17891382
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D2 receptor stimulation alters G-protein expression in rat pituitary intermediate lobe melanotropes.
Sands SA; Dickerson DS; Morris SJ; Chronwall BM
Endocrine; 1997 Jun; 6(3):325-33. PubMed ID: 9368690
[TBL] [Abstract][Full Text] [Related]
7. Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man.
Martin-Iverson MT
J Psychopharmacol; 1999; 13(2):198-9. PubMed ID: 10475729
[No Abstract] [Full Text] [Related]
8. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia.
O'Neill MJ; Hicks CA; Ward MA; Cardwell GP; Reymann JM; Allain H; Bentué-Ferrer D
Eur J Pharmacol; 1998 Jul; 352(1):37-46. PubMed ID: 9718265
[TBL] [Abstract][Full Text] [Related]
10. Effects of D2 dopamine receptor agonist and antagonist on brain activity in the rat assessed by functional magnetic resonance imaging.
Hagino H; Tabuchi E; Kurachi M; Saitoh O; Sun Y; Kondoh T; Ono T; Torii K
Brain Res; 1998 Dec; 813(2):367-73. PubMed ID: 9838195
[TBL] [Abstract][Full Text] [Related]
11. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
[TBL] [Abstract][Full Text] [Related]
12. Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: a D3 receptor mediated effect?
Boulay D; Depoortere R; Perrault G; Sanger DJ
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Jan; 24(1):39-49. PubMed ID: 10659982
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous Eye Blink Rate (EBR) Is Uncorrelated with Dopamine D2 Receptor Availability and Unmodulated by Dopamine Agonism in Healthy Adults.
Dang LC; Samanez-Larkin GR; Castrellon JJ; Perkins SF; Cowan RL; Newhouse PA; Zald DH
eNeuro; 2017; 4(5):. PubMed ID: 28929131
[TBL] [Abstract][Full Text] [Related]
14. Computational modelling reveals contrasting effects on reinforcement learning and cognitive flexibility in stimulant use disorder and obsessive-compulsive disorder: remediating effects of dopaminergic D2/3 receptor agents.
Kanen JW; Ersche KD; Fineberg NA; Robbins TW; Cardinal RN
Psychopharmacology (Berl); 2019 Aug; 236(8):2337-2358. PubMed ID: 31324936
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
[TBL] [Abstract][Full Text] [Related]
16. The role of D2-like dopamine receptors in the locomotor stimulant effects of cocaine in mice.
Chausmer AL; Katz JL
Psychopharmacology (Berl); 2001 Apr; 155(1):69-77. PubMed ID: 11374338
[TBL] [Abstract][Full Text] [Related]
17. Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors.
Piercey MF; Hyslop DK; Hoffmann WE
Brain Res; 1997 Jul; 762(1-2):19-28. PubMed ID: 9262154
[TBL] [Abstract][Full Text] [Related]
18. Effects of dopamine D-1 and D-2 receptors on intraocular pressure in conscious rabbits.
Prünte C; Nuttli I; Markstein R; Kohler C
J Neural Transm (Vienna); 1997; 104(2-3):111-23. PubMed ID: 9203075
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic modulation of risk-based decision making.
St Onge JR; Floresco SB
Neuropsychopharmacology; 2009 Feb; 34(3):681-97. PubMed ID: 18668030
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical evidence of dopamine release by lateral olivocochlear efferents and its presynaptic modulation in guinea-pig cochlea.
Gáborján A; Lendvai B; Vizi ES
Neuroscience; 1999 Apr; 90(1):131-8. PubMed ID: 10188940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
